Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging

CURRENT ISSUE   ARCHIVE   EPUB AHEAD OF PRINT   MOST READ   eTOC

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

Frequency: Quarterly

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus Impact Factor 1,724

P.ISSN 1824-4785

E.ISSN 1827-1936


Editorial Board

Instructions to authors

Authors' statement


Contact the journals department


Activate your subscription

View your subscription


TO SUBSCRIBE  ONLINE SUBMISSION

Most read articles over the last three weeks

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):1-3
PET beyond 18F-FDG: second generation PET tracers in clinical oncology
Brouwers A. H., Glaudemans A. W. J. M., De Vries E. F. J.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):58-69
Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP)
Ambrosini V., Morigi J. J., Nanni C., Castellucci P., Fanti S.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):83-94
Applications of PET imaging with radiolabelled choline (11C/18F-choline)
Kirienko M., Sollini M., Lopci E., Versari A., Chiti A.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):121-8
Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis
Fu H., Ma C., Tang L., Wu F., Liu B., Wang H.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):105-15
Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals
Lauri C., Di Traglia S., Galli F., Pizzichini P., Signore A.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 December;57(4):312-21
Biological subtypes of breast cancer: current concepts and implications for recurrence patterns
Cadoo K. A., Fornier M. N., Morris P. G.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 December;57(4):352-66
Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers
Gaeta C. M., Vercher-Conejero J. L., Sher A. C., Kohan A., Rubbert C., Avril N.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):4-17
Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone
Talbot J.-N., Gligorov J., Nataf V., Montravers F., Huchet V., Michaud L., Ohnona J., Balogova S., Cussenot O., Daraï E., Lotz J.-P., Kerrou K.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):129-35
Precise fusion of MRI and dual energy 111In WBC/99mTc HDP SPECT/CT in the diabetic foot using companion CT: an example of SPECT/MRI imaging
Knešaurek K., Kolker D., Vatti S., Heiba S.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):18-38
89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?
Van Dongen G. A., Huisman M. C., Boellaard R., Harry Hendrikse N., Windhorst A. D., Visser G. W. , Molthoff C. F., Vugts D. J.

top of page